MIDOSTAURIN for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 45 adverse event reports in the FDA FAERS database where MIDOSTAURIN was used for Myelodysplastic syndrome.
Most Reported Side Effects for MIDOSTAURIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 397 | 13.3% | 396 | 22 |
| Nausea | 252 | 8.4% | 21 | 50 |
| Febrile neutropenia | 223 | 7.5% | 33 | 90 |
| Diarrhoea | 194 | 6.5% | 29 | 59 |
| Pyrexia | 188 | 6.3% | 25 | 90 |
| Acute myeloid leukaemia recurrent | 171 | 5.7% | 29 | 14 |
| Pancytopenia | 152 | 5.1% | 11 | 25 |
| Vomiting | 152 | 5.1% | 25 | 45 |
| Drug ineffective | 151 | 5.1% | 18 | 13 |
| Thrombocytopenia | 140 | 4.7% | 17 | 37 |
| Neutropenia | 136 | 4.5% | 15 | 25 |
| Pneumonia | 128 | 4.3% | 47 | 74 |
| Bone marrow failure | 109 | 3.6% | 13 | 14 |
| Sepsis | 106 | 3.5% | 54 | 50 |
| Anaemia | 97 | 3.2% | 17 | 33 |
Other Indications for MIDOSTAURIN
Acute myeloid leukaemia (1,653)
Product used for unknown indication (688)
Systemic mastocytosis (270)
Mastocytic leukaemia (36)
Mastocytosis (36)
Leukaemia (28)
Flt3 gene mutation (16)
Acute leukaemia (15)
Myeloid leukaemia (14)
Malignant mast cell neoplasm (13)
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
REVLIMID (835)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)